Association of plasma proteins at multiple stages of glycation and antioxidant status with erythrocyte oxidative stress in patients with type 2 diabetes

British Journal of Biomedical Science

Volumn 71, Issue 3, 2014, Pages 93-99

  Tupe, R S ^a   Diwan, A G ^b   Mittal, V D ^a   Narayanam, P S ^a   Mahajan, K B ^a  

^a Bharati Vidyapeeth Deemed University   (India)

^b Bharati Vidyapeeth's Medical College   (India)

Author keywords

Antioxidants; Diabetes mellitus, type 2; Erythrocytes; Glycation end products, advanced

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID; CATALASE; FRUCTOSAMINE; GLUTATHIONE; PLASMA PROTEIN; BIOLOGICAL MARKER;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE FRAGILITY; FEMALE; GLYCATION; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSMOTIC FRAGILITY; OXIDATIVE STRESS; PRIORITY JOURNAL; ADULT; AGED; BLOOD; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; OSMOTIC FRAGILITY; OXIDATIVE STRESS;

EID: 84907960010     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2014.11669971     Document Type: Article

References (39)

1. Zheng CM, Ma WY, Wu CC, Lu KC. Glycated albumin in diabetic patients with chronic kidney disease. Clin Chim Acta 2012; 413 (19-20): 1555-61.
2. Cohen MP, Ziyadeh FN, Chen S. Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J Lab Clin Med 2006; 147 (5): 211-9.
3. Grillo MA, Colombatto S. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids 2008; 35 (1): 29-36.
4. Rondeau P, Bourdon E. The glycation of albumin: structural and functional impacts. Biochimie 2011; 93 (4): 645-58.
5. Vetter SW, Indurthi VS. Moderate glycation of serum albumin affects folding: stability and ligand binding. Clin Chim Acta 2011; 412 (23-24): 2105-16.
6. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991; 10 (5): 339-52.
7. Yamagishi S, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim Biophys Acta 2012; 1820 (5): 663-71.
8. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17 (1): 24-38.
9. Grossin N, Wautier MP, Wautier JL. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. Biorheology 2009; 46 (1): 63-72.
10. Zhang Q, Monroe ME, Schepmoes AA et al. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects. J Proteome Res 2011; 10 (7): 3076-88.
11. Porter-Turner MM, Skidmore JC, Khokher MA, Singh BM, Rea CA. Relationship between erythrocyte GLUT1 function and membrane glycation in type 2 diabetes. Br J Biomed Sci 2011; 68 (4): 203-7.
12. Lippi G, Mercadanti M, Aloe R, Targher G. Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. Eur J Intern Med 2012; 23 (2): 150-3.
13. Ramana Devi CH, Hema Prasad M, Padmaja Reddy T, Reddy PP. Glycosylation of hemoglobin and erythrocyte membrane proteins mediated changes in osmotic fragility of erythrocytes. Indian J Med Sci 1997; 51 (1): 5-9.
14. Baker JR, Metcalf PA, Johnson RN, Newman D, Rietz P. Use of protein-based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem 1985; 31 (9): 1550-4.
15. Uchida KM, Kanematsu K, Sakai T. Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 1998; 95 (9): 4882-7.
16. Klunk WE, Jacob RF, Mason RP. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol 1999; 309: 285-305.
17. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82 (1): 70-7.
18. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP Assay. Anal Biochem 1996; 239 (1): 70-6.
19. Raghuramulu N, Nair MK, Kalyanasundaram S. A Manual of Laboratory Techniques. Hyderabad: National Institute of Nutrition, 2003.
20. Placer ZA, Crushman LL, Connor Johnson B. Estimation of products of lipid peroxidation (MDA) in biochemical systems. Anal Chem 1966; 16 (2): 359-64.
21. Aebi H. Catalase in vitro. In: Packer L eds. Methods in Enzymology. New York: Academic Press, 1984: 105, 121-6.
22. Lim HS. Fructosamine and diabetes. Singapore Med J 1988; 29 (6): 541, 543.
23. Pandey KB, Mishra N, Rizvi SI. Protein oxidation biomarkers in plasma of type 2 diabetic patients. Clin Biochem 2010; 43 (4-5): 508-11.
24. Rabbani N, Chittari MV, Bodmer CW, Zehnder D, Ceriello A, Thornalley PJ. Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. Diabetes 2010; 59 (4): 1038-45.
25. Bansal S, Siddarth DM, Banerjee BD, Madhu SV, Tripathi AK. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications. Clin Biochem 2013; 46 (1-2): 109-14.
26. Bouma B, Kroon-Batenburg LM, Wu YP et al. Glycation induces formation of amyloid cross-b structure in albumin. J Biol Chem 2003; 278 (43): 41810-9.
27. Guerin-Dubourg A, Catan A, Bourdon E, Rondeau P. Structural modifications of human albumin in diabetes. Diabetes Metab 2012; 38 (2): 171-8.
28. Wei Y, Chen L, Chen J, Ge L, He RQ. Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells. BMC Cell Biol 2009; 10: 10.
29. Griffin MD, Wilson LM, Mok YF et al. Thioflavin T fluorescence in human serum: Correlations with vascular health and cardiovascular risk factors. Clin Biochem 2010; 43 (3): 278-86.
30. Prakash M, Upadhya S, Prabhu R. Protein thiol oxidation and lipid peroxidation in patients with uremia. Scand J Clin Lab Invest 2004; 64 (4): 599-604.
31. Komosinska-Vassev K, Olczyk P, Winsz-Szczotka K, Klimek K, Olczyk K. Plasma biomarkers of oxidative and AGE-mediated damage of proteins and glycosaminoglycans during healthy ageing: a possible association with ECM metabolism. Mech Ageing Dev 2012; 133 (8): 538-48.
32. Gutteridge J. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41 (12 Pt 2): 1819-28.
33. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987; 924 (3): 408-19.
34. Cao G, Prior RL. Comparison of different analytial methods for assessing total antioxidant capacity of human serum. Clin Chem 1998; 44 (6 Pt 1): 1309-15.
35. Watala C, Witas H, Olszowska L, Piasecki W. The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus. Int J Exp Pathol 1992; 73 (5): 655-63.
36. Wautier J L, Wautier MP, Schmidt AM et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994; 91 (16): 7742-6.
37. Jain SK, McVie R. Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994; 43 (3): 306-9.
38. Riquelme B, Foresto P, D'Arrigo M, Valverde J, Rasia R. Dynamic and stationary rheological study of erythrocytes incubated in a glucose medium. J Biochem Biophys Methods 2005; 62 (2): 131-41.
39. Candiloros H, Muller S, Ziegler O, Donner M, Drouin P. Role of albumin glycation on the erythrocyte aggregation: an in vitro study. Diabet Med 1996; 13 (7): 646-50.